Abnormal modulation of serum osteocalcin by dietary phosphate and 1,25- dihydroxyvitamin D3 in the hypophosphatemic mouse

Journal of Bone and Mineral Research

Volumn 11, Issue 9, 1996, Pages 1234-1240

  Tsuji, H ^a   Cawthorn, C ^c   Ecarot, B ^b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM PHOSPHATE; CYCLIC AMP; OSTEOCALCIN; PARATHYROID HORMONE[1-34]; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HYPOCALCEMIA; HYPOPHOSPHATEMIA; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION;

EID: 0029811014     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110907     Document Type: Article

References (44)

1. Eicher EM, Southard JL, Scriver CR, Glorieux FH 1976 Hypophosphatemia: Mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 73:4667-4671.
2. Rasmussen H, Tenenhouse HS 1989 Hypophosphatemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.) The Metabolic Basis of Inherited Disease, 6th Ed. McGraw-Hill Information Services Co., New York, NY, U.S.A., pp. 2581-2604.
3. Glorieux FH, Scriver CR 1972 Loss of parathyroid hormone sensitive component of phosphate transport in X-linked hypophosphatemia. Science 175:997-1000.
4. Tenenhouse HS, Scriver CR, McInnes RR, Glorieux FH 1978 Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: Evidence for a defect in the brushborder membrane. Kidney Int 14:236-244.
5. Glorieux FH, Bordier PJ, Marie P, Delvin EE, Travers R 1978 Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets (FHR). In: Massy SG, Ritz E, Rapado A (eds.) Homeostasis of phosphate and other minerals. Plenum Publishing Corporation, New York, NY, U.S.A., pp. 227-232.
6. Marie PJ, Travers R, Glorieux FH 1981 Healing of rickets with phosphate supplementation in the hypophosphatemic male mouse. J Clin Invest 67:911-914.
7. Winters RW, Graham JB, Williams TF, McFalls VW, Burnett CH 1958 A genetic study of familial hypophosphatemia and vitamin D-resistant rickets with a review of the literature. Medicine 37:97-142.
8. Frost HM 1958 Some observations on bone mineral in a case of vitamin D resistant rickets. Henry Ford Med Bull 6:300-310.
9. Drezner MK, Lobaugh B, Lyles KW, Carey DE, Paulson DF, Harrelson JM 1982 The pathogenesis and treatment of tumor-induced osteomalacia. In: Norman AW, Schaefer K, von Herrath D, Grigoleit HG (eds.) Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism. Walter de Gruyter, Berlin, Germany, pp. 949-954.
10. Marie PJ, Glorieux FH 1983 Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int 35:443-448.
11. Glorieux FH, Ecarot-Charrier B 1987 X-linked vitamin D-resistant rickets: Is osteoblast activity defective? In: Conn DV, Martin TJ, Meunier PJ (eds.) Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects, Vol 9. Elsevier Science Publishers, Amsterdam, The Netherlands, pp. 227-231.
12. Ecarot-Charrier B, Glorieux FH, Travers R, Desbarats M, Bouchard F, Hinek A 1988 Defective bone formation by transplanted Hyp mouse bone cells into normal mice. Endocrinology 123:768-773.
13. Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L 1992 Defect bone formation by Hyp mouse bone cells transplanted into normal mice: Evidence in favor of an intrinsic osteoblast defect. J Bone Miner Res 7:215-220.
14. Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L 1992 Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res 7:523-530.
15. 3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res 10:424-431.
16. Glorieux FH, Marie PJ, Pettifor J, Delvin EE 1980 Bone response to phosphate salts, ergocalciferol and calcitriol in hypophosphatemic vitamin D-resistant rickets New Engl J Med 303:1023-1031.
17. Harrell RM, Lyles KW, Harrelson JM, Feidman NE, Drezner MK 1985 Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia: Induction and maintenance with phosphorus and calcitriol. J Clin Invest 75:1858-1868.
18. 3 in the young X-linked hypophosphatemic male mouse. Endocrinology 111:904-911.
19. Yamamoto T, Ecarot-Charrier B, Seino Y, Glorieux FH 1990 Familial hypophosphatemia: Altered regulation of osteocalcin synthesis in bone cells. In: Cohn DV, Glorieux FH, Martin TJ (eds.) Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects. Elsevier Science Publishers, Amsterdam, The Netherlands, pp. 239-241.
20. 3. Bone 13:209-215.
21. Delmas PD 1993 Biochemical markers of bone turnover. J Bone Miner Res 8 (Suppl. 2):S549-S555.
22. Price PA, Baukol SA 1980 1,25-dihydroxyvitamin D increases synthesis of the vitamin D-dependent bone protein by osteosarcoma cells. J Biol Chem 225:11660-11663.
23. 3, parathyroid hormone and glucocorticoids. Metab Bone Dis Rel Res 5:229-234.
24. 3 increases serum levels of the vitamin K-dependent bone protein. Biochem Biophys Res Commun 99:928-935.
25. 3. J Clin Endocrinol Metab 56:1063-1067.
26. 3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis. J Clin Endocrinol Metab 60:615-617.
27. Gundberg CM, Clough ME, Carpenter TO 1992 Development and validation of a radioimmunoassay for mouse osteocalcin: Paradoxical response in the Hyp mouse. Endocrinology 130:1909-1915.
28. Tanaka H, Seino Y, Shima M, Yamaoka K, Yabuuchi H, Yoshikawa H, Masuhara K, Takaoka K, Ono K 1988 Effect of phosphorus supplementation on bone formation induced by osteosarcoma derived bone-inducing substance in X-linked hypophosphatemic mice. Bone Miner 4:237-246.
29. Eisman JA, Hamstra AJ, Kream BE, DeLuca HF 1976 A sensitive, precise and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. Arch Biochem Biophys 176:235-243.
30. Gundberg CM, Grant FD, Conlin PR, Chen CJ, Brown EM, Johnson PJ, LeBoff MS 1991 Acute changes in serum osteocalcin during induced hypocalcemia in humans. J Clin Endocrinol Metab 72:438-443.
31. Kiebzak GH, Roos BA, Meyer RA 1982 Secondary hyperparathyroidism in X-linked hypophosphatemic mice. Endocrinology 111:650-652.
32. Demiaux B, Arlot ME, Chapuy M-C, Meunier PJ, Delmas PD 1992 Serum osteocalcin is increased in patients with osteomalacia: Correlations with biochemical and histomorphometric findings. J Clin Endocrinol Metab 74:1146-1151.
33. Riggs BL, Tsai KS, Mann KG 1984 Evidence that serum bone Gla-protein is a measure of bone formation but not of bone resorption. Calcif Tissue Int 36:497-502.
34. Tenenhouse HS, Martel J, Rubin J, Harvey N 1994 Effect of phosphate supplementation on the expression of the mutant phenotype in murine X-linked hypophosphatemic rickets. Bone 15:677-683.
35. Kiebzak M, Meyer RA 1982 X-linked hypophosphatemic mice are not hypersensitive to parathyroid hormone. Endocrinology 110:1030-1036.
36. Nesbitt T, Drezner MK, Lobaugh B 1986 Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1α-hydroxylase activity in the hypophosphatemic mouse: Evidence for a generalized defect of vitamin D metabolism. J Clin Invest 77:181-187.
37. Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B 1991 Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Miner 14:237-250.
38. Fraher L, Hodsman AB, Jonas K, Saunders D, Rose CI, Henderson JE, Hendy GN, Goltzman D 1992 A comparison of the in vivo biochemical responses to exogenous parathyroid hormone (1-34) and parathyroid hormone-related peptide (1-34) in man. J Clin Endocrinol Metab 75:417-423.
39. Cole DEC, Gundberg CM 1985 Changes in serum osteocalcin associated with parathyroid hormone infusion in X-linked hypophosphatemic rickets. Clin Chim Acta 151:1-7.
40. Meyer RA, Jr, Morgan PL, Meyer MH 1994 Mesurement of parathyroid hormone in the mouse: Secondary hyperparathyroidism in the X-linked hypophosphatemic (Gyro, Gy) mouse. Endocrine 2:1127-1132.
41. Marie PJ, Travers R, Glorieux FH 1982 Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif Tissue Int 34:158-164.
42. 3-24-hydroxylase. Endocrinology 120:609-616.
43. 3. J Bone Miner Res 3:151-157.
44. Meyer MH, Meyer RA Jr, Gray RW, Irwin R 1985 Picric acid methods greatly overestimate serum creatinine in mice: More accurate results with high-performance liquid chromatography. Anal Biochem 144:258-290.